Jeffrey McCullough (J McCullough)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Infectious Diseases

Candida Albicans

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Scott A Koepsell, Moritz Stolla, Rebecca L Sedjo, Jeffrey L Carson, Charles Michael Knudson, Richard Cook, Ross M Fasano, Samantha G Ngamsuntikul, Claudia S Cohn, Jed Gorlin, Meghan Delaney, Sherrill Slichter, Paul Ness, Jeffrey McCullough
Results of clinical effectiveness of conventional versus Mirasol-treated Apheresis Platelets in Patients with Hypoproliferative Thrombocytopenia (MiPLATE) trial. Transfusion 64 (3) (2024)
Scott A Koepsell, Moritz Stolla, Rebecca L Sedjo, Jeffrey L Carson, Charles Michael Knudson, Richard Cook, Ross M Fasano, Samantha G Ngamsuntikul, Claudia S Cohn, Jed Gorlin, Meghan Delaney, Sherrill Slichter, Paul Ness, Jeffrey McCullough
Results of clinical effectiveness of conventional versus Mirasol-treated Apheresis Platelets in Patients with Hypoproliferative Thrombocytopenia (MiPLATE) trial. Transfusion (2024)
Scott A Koepsell, Moritz Stolla, Rebecca L Sedjo, Jeffrey L Carson, Charles Michael Knudson, Richard Cook, Ross M Fasano, Samantha G Ngamsuntikul, Claudia S Cohn, Jed Gorlin, Meghan Delaney, Sherrill Slichter, Paul Ness, Jeffrey McCullough
Results of clinical effectiveness of conventional versus Mirasol-treated Apheresis Platelets in Patients with Hypoproliferative Thrombocytopenia (MiPLATE) trial. Transfusion 64 (3) (2024)
Scott A Koepsell, Moritz Stolla, Rebecca L Sedjo, Jeffrey L Carson, Charles Michael Knudson, Richard Cook, Ross M Fasano, Samantha G Ngamsuntikul, Claudia S Cohn, Jed Gorlin, Meghan Delaney, Sherrill Slichter, Paul Ness, Jeffrey McCullough
Results of clinical effectiveness of conventional versus Mirasol-treated Apheresis Platelets in Patients with Hypoproliferative Thrombocytopenia (MiPLATE) trial. Transfusion 64 (3) (2024)
Evan M Bloch, Dorothy Kyeyune, Jodie L White, Henry Ddungu, Swetha Ashokkumar, Feben Habtehyimer, Owen Baker, Ronnie Kasirye, Eshan U Patel, M Kate Grabowski, Ezra Musisi, Khan Moses, Heather A Hume, Irene Lubega, Ruchee Shrestha, Mahnaz Motevalli, Reinaldo E Fernandez, Steven J Reynolds, Andrew D Redd, Hellen Wambongo Musana, Aggrey Dhabangi, Joseph Ouma, Priscilla Eroju, Telsa de Lange, Mary Glenn Fowler, Philippa Musoke, Susan L Stramer, Denise Whitby, Peter A Zimmerman, Jeffrey McCullough, Jaiprasath Sachithanandham, Andrew Pekosz, Raymond P Goodrich, Thomas C Quinn, Paul M Ness, Oliver Laeyendecker, Aaron A R Tobian
SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022. Transfusion (2023)
Jeffrey McCullough
Inflections in a career: Recognizing these and making choices. Transfusion 62 (3) (2022)
Gines Escolar, Maribel Diaz-Ricart, Jeffrey McCullough
Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic. Transfusion (2021)
Paolo Rebulla, Frederic Garban, Pieter F van der Meer, Nancy M Heddle, Jeffrey McCullough
A crosswalk tabular review on methods and outcomes from randomized clinical trials using pathogen reduced platelets. Transfusion 60 (6) (2020)
Lennie To, Tyler Dunnington, Christy Thomas, Kailey Love, Jeffrey McCullough, William Riley
The United States' potential blood donor pool: updating the prevalence of donor-exclusion factors on the pool of potential donors. Transfusion 60 (1) (2019)
Gines Escolar, Jeffrey McCullough
Platelet in vitro assays: their correspondence with their in vivo hemostatic potential. Transfusion 59 (12) (2019)
C Dyer, C R Alquist, M Cole-Sinclair, E Curnow, N M Dunbar, L J Estcourt, R Kaufman, J M Kutner, Jeffrey McCullough, Z McQuilten, L Potiphar, B Rioux-Masse, S Slichter, A Tinmouth, K Webert, A P Yokoyama, Simon J Stanworth, null null
A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy. Vox sanguinis 113 (3) (2018)